Iltefat Hamzavi, MD, Department of Dermatology, Henry Ford Medical Center, discusses his recent research letter that addresses the benefits of ruxolitinib cream for the treatment of vitiligo, and highlights the clinically meaningful use of...
Iltefat Hamzavi, MD, Department of Dermatology, Henry Ford Medical Center, discusses his recent research letter that addresses the benefits of ruxolitinib cream for the treatment of vitiligo, and highlights the clinically meaningful use of...
David Rosmarin, MD, vice chair of education and research, assistant professor, Tufts Medical Center, walks through findings from TRuE-V, a phase 3 program designed to investigate ruxolitinib's efficacy and safety in patients with vitiligo.
David Rosmarin, MD, vice chair of education and research, assistant professor, Tufts Medical Center, walks through findings from TRuE-V, a phase 3 program designed to investigate ruxolitinib's efficacy and safety in patients with vitiligo.
Shawn Kwatra, MD, FAAD, director, Johns Hopkins Itch Center, describes how the atopic dermatitis treatment paradigm has been changing amid increased market competition, as well as where the future of care may be headed.
Shawn Kwatra, MD, FAAD, director, Johns Hopkins Itch Center, describes how the atopic dermatitis treatment paradigm has been changing amid increased market competition, as well as where the future of care may be headed.
Raj Chovatiya, MD, PhD, director, Center for Eczema and Itch, Northwestern University, offers insight into how social determinants of health affect care access and quality for patients with atopic dermatitis.
Raj Chovatiya, MD, PhD, director, Center for Eczema and Itch, Northwestern University, offers insight into how social determinants of health affect care access and quality for patients with atopic dermatitis.
Raj Chovatiya, MD, PhD, director, Center for Eczema and Itch, Northwestern University, shares how severe atopic dermatitis impacts patients' quality of life, as well as what treatment challenges exist for this patient population.
Raj Chovatiya, MD, PhD, director, Center for Eczema and Itch, Northwestern University, shares how severe atopic dermatitis impacts patients' quality of life, as well as what treatment challenges exist for this patient population.
Vivian Shi, MD, FAAD, associate professor of dermatology, University of Arkansas for Medical Sciences, highlights clinical scenarios in which a topical treatment for atopic dermatitis may be most effective.
Vivian Shi, MD, FAAD, associate professor of dermatology, University of Arkansas for Medical Sciences, highlights clinical scenarios in which a topical treatment for atopic dermatitis may be most effective.
Vivian Shi, MD, FAAD, associate professor of dermatology, University of Arkansas for Medical Sciences, provides an overview of a recently approved treatment for atopic dermatitis.
Vivian Shi, MD, FAAD, associate professor of dermatology, University of Arkansas for Medical Sciences, provides an overview of a recently approved treatment for atopic dermatitis.
Gary Owens, MD, president of Gary Owens Associates, shares his thoughts on the challenges of choosing treatment options for patients with atopic dermatitis, and highlights key takeaways for payers from a recent ICER report which compared the...
Gary Owens, MD, president of Gary Owens Associates, shares his thoughts on the challenges of choosing treatment options for patients with atopic dermatitis, and highlights key takeaways for payers from a recent ICER report which compared the...
Steven Feldman, MD, PhD, Wake Forest University School of Medicine, discusses the real-world effectiveness of dupilumab for the treatment of atopic dermatitis, how this data is relevant for payers, and stresses the importance of studying...
Steven Feldman, MD, PhD, Wake Forest University School of Medicine, discusses the real-world effectiveness of dupilumab for the treatment of atopic dermatitis, how this data is relevant for payers, and stresses the importance of studying...
Jonathan Silverberg, MD, PhD, MPH, associate professor of dermatology at The George Washington University School of Medicine and Health Sciences, Washington, DC, offers insight into his real-world data study in which he and his colleagues...
Jonathan Silverberg, MD, PhD, MPH, associate professor of dermatology at The George Washington University School of Medicine and Health Sciences, Washington, DC, offers insight into his real-world data study in which he and his colleagues...
The Supreme Court recently heard arguments in Federal Communication Commission (FCC) v Consumers’ Research, a case that I covered in February and one that could dramatically reshape federal agency authority through the nondelegation...
The Supreme Court recently heard arguments in Federal Communication Commission (FCC) v Consumers’ Research, a case that I covered in February and one that could dramatically reshape federal agency authority through the nondelegation...
On Tuesday, March 25, 2025, the Senate Finance Committee voted to advance Dr Mehmet Oz in his confirmation as the next head of the Centers for Medicare and Medicaid Services (CMS).1 The full Senate vote is expected “soon” (whatever that...
On Tuesday, March 25, 2025, the Senate Finance Committee voted to advance Dr Mehmet Oz in his confirmation as the next head of the Centers for Medicare and Medicaid Services (CMS).1 The full Senate vote is expected “soon” (whatever that...
Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like?
The House of Representatives narrowly passed a budget...
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like?
The House of Representatives narrowly passed a budget...
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
The Plot Thickens in Drug Pricing Drama
Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
The Plot Thickens in Drug Pricing Drama
Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
A proposed state funding initiative in Georgia could significantly reduce financial losses suffered by rural hospitals, but patient advocates argue adoption of Medicaid expansion is more urgent.
A proposed state funding initiative in Georgia could significantly reduce financial losses suffered by rural hospitals, but patient advocates argue adoption of Medicaid expansion is more urgent.
A free water protocol implemented at a long-term acute care hospital improved patients' hydration and quality of life without resulting in aspiration pneumonia, findings show.
A free water protocol implemented at a long-term acute care hospital improved patients' hydration and quality of life without resulting in aspiration pneumonia, findings show.
The findings indicate there "may be an opportunity for added care coordination or resources to optimize therapy transitions" for patients with multiple sclerosis, according to the researchers.
The findings indicate there "may be an opportunity for added care coordination or resources to optimize therapy transitions" for patients with multiple sclerosis, according to the researchers.
Authors of a recent scoping review explored trends in the efficacy and feasibility of implementing pharmacokinetic-guided dosing in clinical practice for patients with bleeding disorders.
Authors of a recent scoping review explored trends in the efficacy and feasibility of implementing pharmacokinetic-guided dosing in clinical practice for patients with bleeding disorders.